SCHEMBL30007565

SCHEMBL30007565

Cc1ccc(S(=O)(=O)n2ncc3c(Br)c(Cl)c(C)cc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
KRAS P01116 2/20 0.39
SLC9A1 P19634 1/20 0.39
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
OPRM1 P35372 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PKM P14618 2/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.36
ALDH3A1 P30838 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
OPRD1 P41143 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23529724 1.00 MAPT (0.40) MAPTKRASSLC9A1PDE4APDE4B
SCHEMBL30761125 0.87 MAPT (0.42) MAPTSLC9A1MEN1KMT2APKM
SCHEMBL23546510 0.84 PDE4A (0.40) MAPTKRASSLC9A1PDE4APDE4B
SCHEMBL30007377 0.82 SLC9A1 (0.42) MAPTSLC9A1OPRM1MEN1KMT2A
SCHEMBL29804193 0.78 KRAS (0.37) MAPTKRASSLC9A1PDE4APDE4B
SCHEMBL23529808 0.78 KRAS (0.41) MAPTKRASSLC9A1PDE4APDE4B
SCHEMBL1118681 0.76 MAPT (0.47) MAPTSLC9A1MEN1KMT2APKM
SCHEMBL14662867 0.75 OPRM1 (0.40) MAPTSLC9A1OPRM1MEN1KMT2A
SCHEMBL27087160 0.74 SLC9A1 (0.42) MAPTSLC9A1OPRM1MEN1KMT2A
SCHEMBL30932761 0.73 ABL1 (0.47) MAPTSLC9A1MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076662-A1 PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS Novartis AG (CH) 2022-10-26 EP disclosed